The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas
Abstract
Phaeochromocytomas arising in adrenal or extra-adrenal sites and paragangliomas of the head and neck, in particular of the carotid bodies, occur sporadically and also in a familial setting. In addition to mutations in RET and VHL in familial disease, germline mutations in SDHD and SDHB genes that encode subunits of mitochondrial complex II have also been associated with the development of familial phaeochromocytomas. To further investigate the role of SDHD and SDHB in the development of these tumours we determined the occurrence of germline SDHD and SDHB mutations in four patients with a family history of phaeochromocytoma with associated head and neck paraganglioma, one patient with a family history of phaeochromocytoma only and two patients with apparently sporadic extra-adrenal phaeochromocytoma, one of whom had early onset disease. Secondly, we investigated whether somatic SDHB mutations correlated with loss of heterozygosity at 1p36 in a subgroup of 11 sporadic and three MEN 2-associated RET-mutation-positive phaeochromocytomas. Novel SDHB mutations were identified in the probands from four families and two apparently sporadic cases (six of seven probands studied), including two missense mutations, a single nonsense and frameshift mutation, as well as two splice site mutations, one of which was shown to have partial penetrance resulting in 'leaky' splicing. Further, five intronic polymorphisms in SDHB were found. No SDHD mutations were identified. In addition, no somatic SDHB mutations were found in the remaining allele of the 11 sporadic adrenal phaeochromocytomas with allelic loss at 1p36 or the three MEN 2-associated RET-mutation-positive phaeochromocytomas. Therefore, we conclude that SDHB has a major role in the pathogenesis of familial phaeochromocytomas, but the possible role of SDHB in sporadic tumours showing allelic loss at 1p36 has yet to be ascertained.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite ubiquitous expression of the metabolic enzyme succinate dehydrogenase (SDH), germline mutations in subunits of this complex cause cancer only in a few sites, including neuroendocrine tissues (paraganglioma), the adrenal gland (pheochromocytoma), and the stomach and small intestine (gastrointestinal stromal tumors) (8–10).”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [9]
Citations
Cites
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,350
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
Mutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Histological Typing of Endocrine Tumours
Solcia, E., Klöppel, G., & Sobin, L. H. (2000) · Springer eBooks · doi:10.1007/978-3-642-59655-1 · Cited by 747
Baysal, B. E., Willett-Brozick, J. E., Lawrence, E. C., Drovdlic, C. M., Savul, S. A., McLeod, D. R., Yee, H. A., Brackmann, D. E., Slattery, W. H., Myers, E. N., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.3.178 · Cited by 336
Germline SDHD mutation in familial phaeochromocytoma
Astuti, D., Douglas, F., Lennard, T. W., Aligianis, I. A., Woodward, E. R., Evans, D. G. R., Eng, C., Latif, F., & Maher, E. R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04378-6 · Cited by 246
Functional Consequences of a SDHB Gene Mutation in an Apparently Sporadic Pheochromocytoma
Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Rieubland, C., Kerlan, V., Plouin, P.-F., Rötig, A., & Jeunemaitre, X. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020525 · Cited by 209
Eng, C., Crossey, P. A., Mulligan, L. M., Healey, C. S., Houghton, C. A., Prowse, A. H., Chew, S. L., Dahia, P. L. M., O'Riordan, J. L. H., & Toledo, S. P. A. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.12.934 · Cited by 167
Taschner, P. E. M., Jansen, J. C., Baysal, B. E., Bosch, A. M., Rosenberg, E. H., Bröcker‐Vriends, A. H. J. T., van der Mey, A. G. L., van Ommen, G. B., Cornelisse, C. J., & Devilee, P. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1144 · Cited by 165
Molecular Genetics of Succinate:Quinone Oxidoreductase in Eukaryotes
Scheffler, I. E. (1998) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60895-8 · Cited by 109
Knudson, A. G. (1993) · Nature Genetics · doi:10.1038/ng1093-103 · Cited by 91
Hofstra, R. M. W., Stelwagen, T., Stulp, R. P., Jong, D. D., Hulsbeek, M. M. F., Kamsteeg, E.-J., van den Berg, A., Landsvater, R. M., Vermey, A., Molenaar, W. M., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768845 · Cited by 79
Phenotypic dichotomy in mitochondrial complex II genetic disorders
Baysal, B. E., Rubinstein, W. S., & Taschner, P. E. M. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100267 · Cited by 77
Localisation of a gene causing endocrine neoplasia to a 4 cM region on chromosome 1p35-p36.
Williamson, C., Pannett, A. A. J., Pang, J. T., Wooding, C., McCarthy, M. I., Sheppard, M. N., Monson, J., Clayton, R. N., & Thakker, R. V. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.8.617 · Cited by 63
Caron, H. N., Spieker, N., Godfried, M. B., Veenstra, M., Sluis, P. V., de Kraker, J., Voûte, P. A., & Versteeg, R. (2000) · Genes Chromosomes and Cancer · doi:10.1002/1098-2264(200102)30:2 · Cited by 61
Genetics of familial paragangliomas
Baysal, B. E. (2001) · Otolaryngologic Clinics of North America · doi:10.1016/s0030-6665(05)70352-2 · Cited by 39
A Second Leaky Splice-Site Mutation in the Spastin Gene
Svenson, I. K., Ashley‐Koch, A. E., Pericak‐Vance, M. A., & Marchuk, D. A. (2001) · The American Journal of Human Genetics · doi:10.1086/324593 · Cited by 37
Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma
Koch, C. A., Huang, S. C., Zhuang, Z., Stolle, C. A., Azumi, N., Chrousos, G. P., Vortmeyer, A. O., & Pacák, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205133 · Cited by 36
Elder, E. E., Nord, B., Carling, T., Juhlin, C., Bäckdahl, M., Höög, A., & Larsson, C. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6626-8 · Cited by 29
Leckschat, S., Ream-Robinson, D., & Scheffler, I. E. (1993) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01233256 · Cited by 22
Familial abdominal chemodectomas with associated cutaneous angiolipomas
Lee, S. P., Nicholson, G. I., & Hitchcock, G. (1977) · Pathology · doi:10.3109/00313027709085255 · Cited by 16
Genetics of pheochromocytoma and paraganglioma
Benn, D. E., Marsh, D. J., & Robinson, B. G. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200202000-00010 · Cited by 9
Self-citation
Research works printed but not linked: 1
- Lack EE . (1997). Atlas of Tumor Pathology: Tumours of the Adrenal Gland and Extra-Adrenal Paraganglia. Rosai J (ed). Armed Forces Institute of Pathology; Washington, pp. 223–259.
Cited by
Sorted by citations
Metabolic reprogramming and cancer progression
Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020) · Science · doi:10.1126/science.aaw5473 · Cited by 2,740
Mitochondrial tumour suppressors: a genetic and biochemical update
Gottlieb, E., & Tomlinson, I. P. M. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1737 · Cited by 626
Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma Syndromes
Benn, D. E., Gimenez‐Roqueplo, A., Reilly, J. R., Bertherat, J. Y., Burgess, J. R., Byth, K., CROXSON, M. S., Dahia, P. L. M., Elston, M. S., Gimm, O., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1862 · Cited by 565
Self-citationMutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez‐Roqueplo, A., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Kien, P. K. V., Corvol, P. L., Plouin, P., & Jeunemaı̂tre, X. (2003) · PubMed · Cited by 542
Pheochromocytoma: State-of-the-Art and Future Prospects
Bravo, E. L., & Tagle, R. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0013 · Cited by 483
Metadata
- Authors
- Benn, D. E., Croxson, M. S., Tucker, K., Bambach, C. P., Richardson, A. L., Delbridge, L., Pullan, P. T., Hammond, J., Marsh, D. J., & Robinson, B. G.
- Affiliations
- The University of Sydney (AU)
- Auckland City Hospital (NZ)
- UNSW Sydney (AU)
- Royal North Shore Hospital (AU)
- The University of Western Australia (AU)
- Corresponding author
- Marsh, Deborah J
- Robinson, Bruce G
- Venue
- Oncogene
- Published
- 2003-03-05
- Volume
- 22
- Issue
- 9
- Pages
- 1358-1364
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1972330784
- Cited by
- 108
- References
- 23
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 5 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 4 · 2013: 2 · 2012: 7
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Keywords
- succinate dehydrogenase subunit B, SDHB mutation, pheochromocytoma, paraganglioma, SDHD, succinate dehydrogenase, germline mutations, somatic mutations, loss of heterozygosity, 1p36, RET mutations, splice site mutation, intronic polymorphism, penetrance
- MeSH terms
- Adolescent, Adrenal Gland Neoplasms, Adult, Australia, Child, Chromosomes, Human, Pair 1, DNA Mutational Analysis, DNA, Neoplasm, Head and Neck Neoplasms, Humans, Introns, Iron-Sulfur Proteins, Male, Middle Aged, Multienzyme Complexes, Neoplasm Proteins, Multiple Endocrine Neoplasia, Neoplastic Syndromes, Hereditary, Oxidoreductases, Paraganglioma, Pedigree, Pheochromocytoma, Retroperitoneal Neoplasms, Succinate Dehydrogenase, Frameshift Mutation, Age of Onset, Germ-Line Mutation, Loss of Heterozygosity, Mutation, Missense, Protein Subunits, RNA Splice Sites, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review